Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy.
about
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studiesAsthma-related deathsGuidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendationsMuscarinic antagonists in early stage clinical development for the treatment of asthma.Sudden death in young persons with uncontrolled asthma--a nationwide cohort study in Denmark."Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study".Inhaled CorticosteroidsAddition of theophylline or increasing the dose of inhaled corticosteroid in symptomatic asthma: a meta-analysis of randomized controlled trials.New therapies and management strategies in the treatment of asthma: patient-focused developments.Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.Update in asthma 2010.Safety of indacaterol in the treatment of patients with COPD.Management of severe asthma in children.Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study.Pituitary adenylate cyclase-activating peptide receptor 1 mediates anti-inflammatory effects in allergic airway inflammation in mice.Asthma prescribing, ethnicity and risk of hospital admission: an analysis of 35,864 linked primary and secondary care records in East London.Unmet needs in asthma treatment in a resource-limited setting: findings from the survey of adult asthma patients and their physicians in Nigeria.Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthmaSafe use of long-acting β-agonists: what have we learnt?Paradoxical and bidirectional drug effects.Eculizumab for treatment of asthma.Asthma phenotyping, therapy, and prevention: what can we learn from systems biology?Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment.Eosinophil apoptosis as a therapeutic target in allergic asthma.Cardiovascular safety of long acting beta agonist-inhaled corticosteroid combination products in adult patients with asthma: a systematic review.Pharmacotherapy of critical asthma syndrome: current and emerging therapies.Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma.The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.Addition to inhaled corticosteroids of leukotriene receptor antagonists versus theophylline for symptomatic asthma: a meta-analysis.Long-acting β-agonists and asthma: the saga continues.What We Need To Know about Long-acting β2-AgonistsUse and safety of long-acting β2-agonists for pediatric asthma
P2860
Q27027449-75AE5A8C-E535-4A72-976A-6D1278F070D7Q28073233-66C8EAF5-A7EA-4230-BC13-9234B3E46089Q28392274-DCDC3FEC-EA4B-42ED-B650-45F8A1E30EFFQ30396144-F9A2213A-DD27-4407-9477-83BE89328931Q33165633-E5D7897C-2B43-4979-B8BE-9AA324FBB357Q33643053-B4577AD0-2CCF-4697-81DD-F2409FB360FAQ33664193-086D63E3-7A7F-491A-AE9A-2A3EBCBCC16BQ34635514-8152D05F-FB82-4BED-B9C7-0E06C396C072Q35025262-333B2742-CBDD-4777-8B04-851CFE83CC45Q35065270-39401ED1-DDEB-4E47-B24F-9E0899B1B298Q35219714-E1D69B98-2771-4290-B0A3-2A30CFEC6EF5Q35268351-29B5E57F-4C6B-48D3-B61D-C90CCDB7F28DQ36316775-45BF39C4-8333-4948-A393-1AE399236A47Q36802786-86F7FE8F-E953-44D7-9E88-C7981F04B9D7Q36959866-88CD5C2E-20CA-4DEF-A7C0-E37EF29B0D41Q37186788-2F1F4296-A4EB-438B-9BD3-1D399387C9B3Q37540677-3E1EF62B-E105-460C-A76F-BAB5434BED94Q37694255-B6D0B362-BBA5-4B21-B615-C21AF41ACABDQ37869146-23C8C6C4-91A7-4DAE-81CF-D4F13B51D8AAQ37978338-48D8A004-BA7E-4F79-8312-535AA7CAF918Q37993121-28682499-F09F-4DDF-B7CA-7C71AB2C979CQ38073596-4C06A150-A69E-48C7-8484-34E65001B8EAQ38091030-049C2BF4-2AD1-4D27-B585-CCC667ACD405Q38154740-57BAB18E-30E5-44FC-A39F-6C00D8277636Q38155066-D7FF0AD6-851F-4307-914D-51B622655C32Q38157770-89142B3D-3D14-4161-98D8-0050170E8C24Q38248438-DB6FB045-9DEC-4C19-8B5B-1B8C3B27A3FCQ38272007-9C56D643-9ABF-4F39-B524-AD9AA5D730E7Q38669520-3FCECFBB-51D9-4560-99F4-437A36C5249BQ40253047-E5692A15-8233-4923-8F6B-254FC5FEBBFAQ44219145-722949D4-E96A-4C4B-B828-D782316C5021Q54981619-63142C41-4269-4ECA-8736-CD3B6FB8FC29Q57821604-29935B24-897F-44A3-88B6-B5FF6C67E9D2
P2860
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Meta-analysis of the risk of m ...... nhaled corticosteroid therapy.
@en
Meta-analysis of the risk of m ...... nhaled corticosteroid therapy.
@nl
type
label
Meta-analysis of the risk of m ...... nhaled corticosteroid therapy.
@en
Meta-analysis of the risk of m ...... nhaled corticosteroid therapy.
@nl
prefLabel
Meta-analysis of the risk of m ...... nhaled corticosteroid therapy.
@en
Meta-analysis of the risk of m ...... nhaled corticosteroid therapy.
@nl
P2093
P356
P1433
P1476
Meta-analysis of the risk of m ...... nhaled corticosteroid therapy.
@en
P2093
M Weatherall
M Wijesinghe
P356
10.1136/THX.2009.116608
P407
P577
2010-01-01T00:00:00Z